HCG launches cancer hospital in North Bengaluru

HealthCare Global Enterprises Limited (HCG) has announced the launch of its new comprehensive cancer hospital in Byatarayanapura (Hebbal), strengthening access to advanced oncology care in North Bengaluru. 

The 110-bed facility introduces Karnataka’s first Elekta Unity MR-Linac. The technology combines MRI imaging with a linear accelerator to enable cancer treatment. 

The total built up area of this facility is 1,75,086 Sqft.

Abhinaya Chakravarthy Baadashah Kichcha Sudeep, Renowned Actor and Director (Sandalwood), who inaugurated the facility said, “Cancer is a journey that affects not just the patient, but the entire family. What makes a real difference is timely diagnosis, awareness, and access to the right treatment at the right time. HCG’s new Hebbal facility is a powerful step in that direction, bringing advanced technology and expert care closer to people. It is heartening to see such world-class cancer care becoming more accessible for families in Bengaluru and across Karnataka.”

Speaking on the launch, Dr B. S. Ajaikumar, Founder and Chairman of HealthCare Global Enterprises Limited (HCG), said, “Cancer care today has become increasingly data-driven, technology-oriented and focused on improving long-term outcomes. Our goal is not only to prevent recurrences, but also to make even advanced and metastatic cancers manageable through personalised, multidisciplinary care.

We are very happy to launch our new centre at Hebbal, North Bengaluru, bringing state-of-the-art infrastructure and Karnataka’s first MR-Linac technology to the region. This marks an important step forward in precision-led cancer treatment and reinforces HCG’s commitment to making advanced oncology care more accessible. As a founder, I have always believed in providing the right treatment to the patient the first time, because that is when we achieve the best outcomes. The launch of our Hebbal centre is another important milestone in HCG’s pursuit of excellence in cancer care.”

Dr Manish Mattoo, Executive Director & CEO, HealthCare Global Enterprises Limited (HCG), said, “HCG Hebbal brings together everything we stand for, people-centric care, multidisciplinary expertise, preventive focus and advanced technology. With MR-Linac, we are introducing a major upgrade to our oncology services and making technology-first cancer care more accessible, especially for people of Karnataka. HCG Hebbal reflects our 35-year legacy of ‘adding life to years’, bringing together clinical excellence, compassionate care, and cutting-edge technology to improve cancer outcomes.”

The hospital is equipped with Accuray TomoTherapy with Radixact along with an 80-slice Digital PET-CT scanner for precise, high-resolution diagnostic imaging. In addition to advanced imaging and radiation therapy, HCG Hebbal features five robotic-assisted modular operation theatres, 19 chemotherapy daycare beds, 14 premium treatment bays, and a 15-bed ICU and HDU. The facility is also supported by diagnostic and clinical services, including endoscopy, bronchoscopy, ultrasound, X-ray, mammography, advanced laboratories, histopathology, frozen section services and blood storage.

“The launch of our Hebbal cancer hospital marks an important milestone in HCG’s continued commitment to expanding access to advanced cancer care in Bengaluru. This new facility brings together our legacy of clinical excellence, compassionate care, and cutting-edge technology in a thoughtfully designed environment”, Manisha Kumar, COO, Karnataka, HCG Cancer Hospital added.

Sachin S.E., COO, HCG Cancer Hospital Hebbal said, “The launch of HCG Hebbal marks a significant expansion of our Bengaluru footprint, strengthening our network in the city while extending advanced oncology services to emerging neighbourhoods. The hospital has been thoughtfully designed to move away from a conventional clinical environment and instead create spaces that inspire comfort, confidence and hope. With the introduction of first-in-Karnataka innovations like the MR-Linac, we are strengthening our ability to deliver precise, personalised treatment. “